Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
P Zhu, X Lai, L Liu, J Shi, J Yu, Y Zhao, L Yang… - Journal of Translational …, 2024 - Springer
Background The prognostic significance of myelofibrosis (MF) grade in patients with
myelodysplastic syndrome (MDS) following an allogeneic hematopoietic stem cell …
myelodysplastic syndrome (MDS) following an allogeneic hematopoietic stem cell …
Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome
X Zeng, L Xuan, Z Fan, Y Zhang, K Zhao… - … Hematology & Oncology, 2021 - Springer
Purpose Myelofibrosis (MF) may serve as a poor prognostic factor in myelodysplastic
syndromes (MDS). This study explored the impact of allogeneic hematopoietic stem cell …
syndromes (MDS). This study explored the impact of allogeneic hematopoietic stem cell …
[HTML][HTML] Long-Term Survival in Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation Using Fludarabine/Melphalan Conditioning Regimen
Allogeneic hematopoietic cell transplantation (AlloHCT) is the only curative approach for
myelofibrosis (MF). However the significant risk of morbidity and mortality associated with …
myelofibrosis (MF). However the significant risk of morbidity and mortality associated with …
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working …
Therapeutic management of patients with primary or secondary myelofibrosis (MF) who
experience relapse or graft failure following allogeneic haematopoietic cell transplantation …
experience relapse or graft failure following allogeneic haematopoietic cell transplantation …
Patients of myelodysplastic syndrome with mild/moderate myelofibrosis and a monosomal karyotype are independently associated with an adverse prognosis: long …
N Wang, H Xu, Q Li, X Fang, J Liu, X Sui… - Cancer Management …, 2020 - Taylor & Francis
Purpose The aim of our study was to evaluate the clinical characteristics of myelodysplastic
syndrome (MDS) patients with concomitant mild-to-moderate myelofibrosis (MF), and to …
syndrome (MDS) patients with concomitant mild-to-moderate myelofibrosis (MF), and to …
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
Survival following allogeneic transplant in patients with myelofibrosis
Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …
[HTML][HTML] Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis—a systematic review and meta-analysis
Allogeneic hematopoietic cell transplant (allo-HCT) remains the only potentially curative
therapeutic modality for patients with primary or secondary myelofibrosis (MF). However …
therapeutic modality for patients with primary or secondary myelofibrosis (MF). However …
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
R Tamari, DP McLornan, KW Ahn… - Blood …, 2023 - ashpublications.org
To develop a prognostic model for patients undergoing allogeneic hematopoietic cell
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
Importance of allogeneic stem cell transplantation in myelofibrosis
K Hirschbühl, C Schmid - memo-Magazine of European Medical Oncology, 2024 - Springer
Allogeneic stem cell transplantation (alloSCT) is the only curative treatment option for
patients with high-risk myelofibrosis (MF). However, it is important to bear in mind that …
patients with high-risk myelofibrosis (MF). However, it is important to bear in mind that …
相关搜索
- patients with myelofibrosis cell transplantation
- patients with myelofibrosis allogeneic transplant
- impact of myelofibrosis myelodysplastic syndromes
- survival outcomes cell transplantation
- adverse prognosis myelodysplastic syndrome
- patients with myelofibrosis meta analysis
- meta analysis cell transplantation
- monosomal karyotype myelodysplastic syndrome
- conditioning regimen cell transplantation
- adverse impact myelodysplastic syndrome